PMID- 32408168 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210110 IS - 2589-0042 (Electronic) IS - 2589-0042 (Linking) VI - 23 IP - 5 DP - 2020 May 22 TI - Contribution of Prostaglandin Transporter OATP2A1/SLCO2A1 to Placenta-to-Maternal Hormone Signaling and Labor Induction. PG - 101098 LID - S2589-0042(20)30283-2 [pii] LID - 10.1016/j.isci.2020.101098 [doi] LID - 101098 AB - We evaluated the contribution of organic anion transporting polypeptide 2A1 (OATP2A1/SLCO2A1), a high-affinity carrier for prostaglandins (PGs), to the parturition process. At gestational day (GD) 15.5, OATP2A1 is co-localized with 15-hydroxy-PG dehydrogenase in the mouse placental junctional zone and facilitates PG degradation by delivering PGs to the cytoplasm. Slco2a1 (+/-) females mated with Slco2a1 (-/-) males frequently showed elevated circulating progesterone at GD18.5 and delayed parturition. Progesterone receptor inhibition by RU486 treatment at GD18.5 blocked the delay of parturition. In the junctional zone, PGE(2) stimulated placental lactogen II (PL-II) production, resulting in higher expression of PL-II in Slco2a1 (-/-) placenta at GD18.5. Indomethacin treatment at GD15.5 suppressed the PL-II overproduction at GD18.5 in Slco2a1 (-/-) embryo-bearing dams, which promoted progesterone withdrawal and corrected the delayed parturition. These results suggest that extracellular PGE(2) reduction by OATP2A1 at mid-pregnancy would be associated with progesterone withdrawal by suppressing PL-II production, triggering parturition onset. CI - Copyright (c) 2020 The Author(s). Published by Elsevier Inc. All rights reserved. FAU - Inagaki, Mai AU - Inagaki M AD - Faculty of Pharmacy, Keio University, Minato-ku, Tokyo 105-8512, Japan. FAU - Nishimura, Tomohiro AU - Nishimura T AD - Faculty of Pharmacy, Keio University, Minato-ku, Tokyo 105-8512, Japan. FAU - Nakanishi, Takeo AU - Nakanishi T AD - Faculty of Pharmacy, Takasaki University of Health and Welfare, Takasaki, Gunma 370-0033, Japan; Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa 920-1192, Japan. FAU - Shimada, Hiroaki AU - Shimada H AD - Faculty of Pharmacy, Kindai University, Higashiosaka, Osaka 577-8502, Japan. FAU - Noguchi, Saki AU - Noguchi S AD - Faculty of Pharmacy, Keio University, Minato-ku, Tokyo 105-8512, Japan. FAU - Akanuma, Shin-Ichi AU - Akanuma SI AD - Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan. FAU - Tachikawa, Masanori AU - Tachikawa M AD - Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan. FAU - Hosoya, Ken-Ichi AU - Hosoya KI AD - Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan. FAU - Tamai, Ikumi AU - Tamai I AD - Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa 920-1192, Japan. FAU - Nakashima, Emi AU - Nakashima E AD - Faculty of Pharmacy, Keio University, Minato-ku, Tokyo 105-8512, Japan. FAU - Tomi, Masatoshi AU - Tomi M AD - Faculty of Pharmacy, Keio University, Minato-ku, Tokyo 105-8512, Japan. Electronic address: tomi-ms@pha.keio.ac.jp. LA - eng PT - Journal Article DEP - 20200427 PL - United States TA - iScience JT - iScience JID - 101724038 PMC - PMC7225742 OTO - NOTNLM OT - Endocrinology OT - Molecular Biology COIS- Declaration of Interests The authors declare no conflict of interest. EDAT- 2020/05/15 06:00 MHDA- 2020/05/15 06:01 PMCR- 2020/04/27 CRDT- 2020/05/15 06:00 PHST- 2020/01/15 00:00 [received] PHST- 2020/03/22 00:00 [revised] PHST- 2020/04/21 00:00 [accepted] PHST- 2020/05/15 06:00 [pubmed] PHST- 2020/05/15 06:01 [medline] PHST- 2020/05/15 06:00 [entrez] PHST- 2020/04/27 00:00 [pmc-release] AID - S2589-0042(20)30283-2 [pii] AID - 101098 [pii] AID - 10.1016/j.isci.2020.101098 [doi] PST - ppublish SO - iScience. 2020 May 22;23(5):101098. doi: 10.1016/j.isci.2020.101098. Epub 2020 Apr 27.